Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
oxidative stress3585 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27348 | 18596193 | Gut | Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. | 2008 | Details |
| A27353 | 21479447 | Mol Med Rep | Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis. | 2012 | Details |
| A27366 | 18532991 | Aliment Pharmacol Ther | Review article: diagnosis and treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27374 | 19669305 | Hepatol Int | Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease. | 2008 | Details |
| A27384 | 18501344 | Eur J Pharmacol | Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. | 2008 | Details |
| A27388 | 18492019 | Liver Int | Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease. | 2008 | Details |
| A27391 | 18486983 | J Hepatol | Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. | 2008 | Details |
| A27409 | 18452148 | Hepatology | Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. | 2008 | Details |
| A27410 | 18445359 | Curr Diab Rep | Genes and nonalcoholic fatty liver disease. | 2008 | Details |
| A27420 | 18419637 | J Dig Dis | Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. | 2008 | Details |
| A27424 | 18410557 | Aliment Pharmacol Ther | Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2008 | Details |
| A27430 | 18397387 | Aliment Pharmacol Ther | Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. | 2008 | Details |
| A27435 | 18391799 | Gastroenterol Nurs | Pediatric nonalcoholic fatty liver disease. | 2008 | Details |
| A27448 | 18370830 | Metab Syndr Relat Disord | Nonalcoholic steatohepatitis and the metabolic syndrome. | 2008 | Details |
| A27453 | 18367854 | Korean J Hepatol | [Nonalcoholic steatohepatitis: pathogenesis and treatment]. | 2008 | Details |
| A27481 | 18308829 | Gut | Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. | 2008 | Details |
| A27489 | 18296738 | Exp Biol Med (Maywood) | Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver. | 2008 | Details |
| A27494 | 18273497 | Rom J Morphol Embryol | Nonalcoholic fatty liver disease and metabolic syndrome: a concise review. | 2008 | Details |
| A27499 | 18264740 | Obes Surg | Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity. | 2008 | Details |
| A27511 | 18220286 | Hepatology | Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. | 2008 | Details |
| A27512 | 18220271 | Hepatology | The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. | 2008 | Details |
| A27516 | 18218340 | Trends Mol Med | Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. | 2008 | Details |
| A27522 | 18198478 | J Toxicol Sci | Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. | 2007 | Details |
| A27527 | 18181765 | Clin Sci (Lond) | Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease. | 2008 | Details |
| A27540 | 18158823 | J Med Food | Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. | 2007 | Details |
| A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
| A27549 | 18086506 | J Hepatol | Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. | 2007 | Details |
| A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
| A27571 | 18035683 | Verh Dtsch Ges Pathol | [Alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
| A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |
| A27579 | 18007554 | Ann Hepatol | Dipeptidyl peptidase IV (DDP IV) in NASH patients. | 2008 | Details |
| A27586 | 17986629 | Am J Physiol Endocrinol Metab | Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. | 2007 | Details |
| A27602 | 17932230 | Am J Physiol Gastrointest Liver Physiol | The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. | 2007 | Details |
| A27608 | 17914984 | J Gastroenterol Hepatol | Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. | 2007 | Details |
| A27620 | 17900521 | Biochim Biophys Acta | Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. | 2007 | Details |
| A27636 | 17867371 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. | 2007 | Details |
| A27639 | 17845148 | Expert Opin Ther Targets | Present and future therapeutic strategies in non-alcoholic fatty liver disease. | 2007 | Details |
| A27641 | 17823431 | Am J Clin Nutr | Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. | 2007 | Details |
| A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
| A27660 | 17567476 | J Gastroenterol Hepatol | Role of adipocytokines in hepatic fibrogenesis. | 2007 | Details |
| A27661 | 17567475 | J Gastroenterol Hepatol | Role of oxidative stress and Kupffer cells in hepatic fibrosis. | 2007 | Details |
| A27662 | 17567459 | J Gastroenterol Hepatol | Role of mitochondria in non-alcoholic fatty liver disease. | 2007 | Details |
| A27668 | 17708600 | World J Gastroenterol | Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. | 2007 | Details |
| A27681 | 17683488 | J Gastroenterol Hepatol | Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. | 2007 | Details |
| A27688 | 17661414 | Hepatology | Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. | 2007 | Details |
| A27695 | 17654601 | Hepatology | Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. | 2007 | Details |
| A27700 | 17628189 | Vitam Horm | Vitamin E in chronic liver diseases and liver fibrosis. | 2007 | Details |
| A27701 | 17627552 | Curr Pharm Des | Non-alcoholic fatty liver disease in the metabolic syndrome. | 2007 | Details |
| A27702 | 17619535 | Acta Gastroenterol Belg | Pathogenesis of steatohepatitis: insights from the study of animal models. | 2007 | Details |
| A27708 | 17605315 | Nutr Rev | Obesity and nonalcoholic fatty liver disease. | 2007 | Details |
| A27743 | 17542283 | Rev Gastroenterol Mex | [Therapeuric aspects of NAFLD. A literature review]. | 2007 | Details |
| A27751 | 17520517 | Semin Liver Dis | The role of cytokines and chemokines in the development of steatohepatitis. | 2007 | Details |
| A27753 | 17519829 | Ann Hepatol | The genetics of nonalcoholic fatty liver disease. | 2007 | Details |
| A27755 | 17512085 | J Hepatol | Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. | 2007 | Details |
| A27762 | 17496361 | Indian J Med Res | Antioxidants: do they have a role in the treatment of insulin resistance? | 2007 | Details |
| A27767 | 17487136 | J Med Assoc Thai | Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis. | 2007 | Details |
| A27774 | 17476695 | Hepatology | Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. | 2007 | Details |
| A27777 | 17471859 | Rev Gastroenterol Mex | Nonalcoholic fatty liver disease. | 2005 | Details |
| A27799 | 17402991 | Aliment Pharmacol Ther | GI epidemiology: nonalcoholic fatty liver disease. | 2007 | Details |
| A27814 | 17376040 | J Gastroenterol Hepatol | Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. | 2007 | Details |
| A27824 | 17353063 | Diabetes Res Clin Pract | The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. | 2007 | Details |
| A27830 | 17324404 | Gastroenterology | Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. | 2006 | Details |
| A27839 | 17296492 | J Nutr Biochem | Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. | 2007 | Details |
| A27841 | 17295176 | Semin Liver Dis | Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. | 2007 | Details |
| A27853 | 17253535 | Cochrane Database Syst Rev | Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. | 2007 | Details |
| A27859 | 17230603 | World J Gastroenterol | Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. | 2007 | Details |
| A27860 | 17228028 | Obesity (Silver Spring) | Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. | 2007 | Details |
| A27870 | 17201732 | Clin Exp Pharmacol Physiol | Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. | 2007 | Details |
| A27871 | 17198477 | Rev Esp Enferm Dig | Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. | 2006 | Details |
| A27882 | 17143543 | Int J Mol Med | Pulmonary exposure to diesel exhaust particles enhances fatty change of the liver in obese diabetic mice. | 2007 | Details |
| A27891 | 17096066 | J Gastroenterol | Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. | 2006 | Details |
| A27892 | 17074020 | J Gastroenterol Hepatol | Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. | 2006 | Details |
| A27898 | 17063114 | J Clin Gastroenterol | Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27906 | 17049925 | Trends Mol Med | Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. | 2006 | Details |
| A27911 | 17034663 | J Pharm Pharmacol | Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. | 2006 | Details |
| A27913 | 17032401 | Liver Int | Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. | 2006 | Details |
| A27933 | 16958667 | J Gastroenterol Hepatol | Mitochondrial glutathione: hepatocellular survival-death switch. | 2006 | Details |
| A27934 | 16956020 | Praxis (Bern 1994) | [Non-alcoholic liver disease (NASH)]. | 2006 | Details |
| A27937 | 16949573 | Exp Mol Pathol | Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. | 2006 | Details |
| A27950 | 16912563 | Curr Opin Clin Nutr Metab Care | Non-alcoholic steatohepatitis and metabolic syndrome. | 2006 | Details |
| A27963 | 16865855 | Orv Hetil | [Antioxidant therapy in chronic liver diseases]. | 2006 | Details |
| A27964 | 16865780 | World J Gastroenterol | Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. | 2006 | Details |
| A27969 | 16842545 | J Pineal Res | Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. | 2006 | Details |
| A27993 | 16768124 | Nihon Rinsho | [Clinical utility of angiotensin II receptor antagonist]. | 2006 | Details |
| A28010 | 28316519 | Gastroenterol Hepatol (N Y) | Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment. | 2006 | Details |
| A28031 | 16679470 | Postgrad Med J | Treatment of non-alcoholic fatty liver disease. | 2006 | Details |
| A28032 | 16673555 | Acta Gastroenterol Belg | Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. | 2006 | Details |
| A28041 | 16618517 | J Hepatol | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. | 2006 | Details |
| A28050 | 16573713 | Fundam Clin Pharmacol | Effect of hyperleptinaemia on chronic ethanol-induced hepatotoxicity in mice. | 2006 | Details |
| A28055 | 16557185 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease and hepatitis C infection. | 2006 | Details |
| A28065 | 16540762 | J Clin Gastroenterol | Pathophysiology of nonalcoholic steatohepatitis. | 2006 | Details |
| A28080 | 16672820 | J Clin Gastroenterol | Pathophysiology of Nonalcoholic Steatohepatitis. | 2006 | Details |
| A28081 | 16496750 | Recenti Prog Med | [Steatosis and hepatitis C]. | 2005 | Details |
| A28082 | 16496325 | Hepatology | Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. | 2006 | Details |
| A28095 | 16447287 | Hepatology | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | 2006 | Details |
| A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
| A28113 | 16393285 | Aliment Pharmacol Ther | Blood oxidative stress markers are unreliable markers of hepatic steatosis. | 2006 | Details |
| A28115 | 16385233 | Alcohol Clin Exp Res | Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. | 2005 | Details |
| A28120 | 16374859 | Hepatology | Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. | 2006 | Details |
| A28121 | 16374858 | Hepatology | JNK1 but not JNK2 promotes the development of steatohepatitis in mice. | 2006 | Details |